The IMPACT Trial:Single Inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients with COPD. Results on Cardiovascular Safety

MLA

Lipson, D. A., et al. “The IMPACT Trial:Single Inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients with COPD. Results on Cardiovascular Safety.” Lipson , D A , Criner , G , Dransfield , M T , Halpin , D M G , Han , M K , Jones , C E , Kilbride , S , Lange , P , Lomas , D A , Martinez , F J , Pascoe , S , Singh , D & Wise , R A 2019 , ’ The IMPACT Trial : Single Inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients with COPD. Results on Cardiovascular Safety ’ , American Journal of Respiratory and Critical Care Medicine , Vol. 199 , No. A3334 , B45 . <, 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1322725987&authtype=sso&custid=ns315887.

APA

Lipson, D. A., Criner, G., Dransfield, M. T., Halpin, D. M. G., Han, M. K., Jones, C. E., Kilbride, S., Lange, P., Lomas, D. A., Martinez, F. J., Pascoe, S., Singh, D., & Wise, R. A. (2019). The IMPACT Trial:Single Inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients with COPD. Results on Cardiovascular Safety. Lipson , D A , Criner , G , Dransfield , M T , Halpin , D M G , Han , M K , Jones , C E , Kilbride , S , Lange , P , Lomas , D A , Martinez , F J , Pascoe , S , Singh , D & Wise , R A 2019 , ’ The IMPACT Trial : Single Inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients with COPD. Results on Cardiovascular Safety ’ , American Journal of Respiratory and Critical Care Medicine , Vol. 199 , No. A3334 , B45 . <.

Chicago

Lipson, D. A., G. Criner, M. T. Dransfield, D. M. G. Halpin, M. K. Han, C. E. Jones, S. Kilbride, et al. 2019. “The IMPACT Trial:Single Inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients with COPD. Results on Cardiovascular Safety.” Lipson , D A , Criner , G , Dransfield , M T , Halpin , D M G , Han , M K , Jones , C E , Kilbride , S , Lange , P , Lomas , D A , Martinez , F J , Pascoe , S , Singh , D & Wise , R A 2019 , ’ The IMPACT Trial : Single Inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients with COPD. Results on Cardiovascular Safety ’ , American Journal of Respiratory and Critical Care Medicine , Vol. 199 , No. A3334 , B45 . <. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1322725987&authtype=sso&custid=ns315887.